Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00152776Phase 4Completed
Phase 4, randomised, double-blind trial of Ovaria comp in menopause (3 arms), sponsored by Heidelberg University. Primary endpoint: Menopause Rating Scale II at 12 weeks. Started Feb 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00152776.